Bio-Techne (TECH) Net Income towards Common Stockholders (2009 - 2026)

Bio-Techne's Net Income towards Common Stockholders history runs 18 years deep, the most recent figure standing at $51.0 million for Q1 2026.

• In Q1 2026, Net Income towards Common Stockholders rose 125.99% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $22.7 million (down 71.78% YoY), while the FY2025 annual figure was -$13.4 million, down 111.46% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at $51.0 million, up from $38.0 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was $89.7 million in Q3 2022, with the low at -$104.5 million in Q2 2025.
• The 5-year median for Net Income towards Common Stockholders is $49.1 million (2024), against an average of $38.0 million.
• The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders jumped 615.95% in 2022, then slumped 899.35% in 2025.
• Bio-Techne's Net Income towards Common Stockholders stood at $50.0 million in 2022, then plunged by 45.08% to $27.5 million in 2023, then gained by 27.03% to $34.9 million in 2024, then gained by 8.94% to $38.0 million in 2025, then soared by 34.3% to $51.0 million in 2026.
• Business Quant data shows TECH's Net Income towards Common Stockholders at $51.0 million in Q1 2026, $38.0 million in Q4 2025, and $38.2 million in Q3 2025.